164 related articles for article (PubMed ID: 17223910)
1. Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia.
Eggleston B; Patience M; Edwards S; Adamkiewicz T; Buchanan GR; Davies SC; Dickerhoff R; Donfield S; Feig SA; Giller RH; Haight A; Horan J; Hsu LL; Kamani N; Lane P; Levine JE; Margolis D; Moore TB; Ohene-Frempong K; Redding-Lallinger R; Roberts IA; Rogers ZR; Sanders JE; Scott JP; Sleight B; Thompson AA; Sullivan KM; Walters MC;
Br J Haematol; 2007 Feb; 136(4):673-6. PubMed ID: 17223910
[TBL] [Abstract][Full Text] [Related]
2. The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia.
Elchuri SV; Williamson RS; Clark Brown R; Haight AE; Spencer JB; Buchanan I; Hassen-Schilling L; Brown MR; Mertens AC; Meacham LR
Blood Cells Mol Dis; 2015 Jun; 55(1):56-61. PubMed ID: 25976468
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydroxyurea on growth in children with sickle cell anemia: results of the HUG-KIDS Study.
Wang WC; Helms RW; Lynn HS; Redding-Lallinger R; Gee BE; Ohene-Frempong K; Smith-Whitley K; Waclawiw MA; Vichinsky EP; Styles LA; Ware RE; Kinney TR
J Pediatr; 2002 Feb; 140(2):225-9. PubMed ID: 11865275
[TBL] [Abstract][Full Text] [Related]
4. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial.
Wang WC; Morales KH; Scher CD; Styles L; Olivieri N; Adams R; Brambilla D;
J Pediatr; 2005 Aug; 147(2):244-7. PubMed ID: 16126058
[TBL] [Abstract][Full Text] [Related]
5. Management of sickle cell disease.
Steinberg MH
N Engl J Med; 1999 Apr; 340(13):1021-30. PubMed ID: 10099145
[No Abstract] [Full Text] [Related]
6. Sickle cell anaemia: current therapies.
Vermylen C
Transfus Apher Sci; 2013 Oct; 49(2):151-4. PubMed ID: 23954416
[TBL] [Abstract][Full Text] [Related]
7. Hydroxycarbamide use in young children with sickle-cell anaemia.
Takahashi Y; Mori J; Tsubokura M; Matsumura T; Kami M
Lancet; 2011 Nov; 378(9805):1777. PubMed ID: 22098851
[No Abstract] [Full Text] [Related]
8. Hydroxycarbamide use in young children with sickle-cell anaemia.
Obaro SK; Inusa B; Telfer P
Lancet; 2011 Nov; 378(9805):1777. PubMed ID: 22098850
[No Abstract] [Full Text] [Related]
9. Bone marrow transplantation or hydroxyurea for sickle cell anemia: long-term effects on semen variables and hormone profiles.
Lukusa AK; Vermylen C; Vanabelle B; Curaba M; Brichard B; Chantrain C; Dupont S; Ferrant A; Wyns C
Pediatr Hematol Oncol; 2009 Jun; 26(4):186-94. PubMed ID: 19437321
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyurea for sickle-cell anaemia in Africa: mind the gap.
Obaro SK
Lancet Glob Health; 2015 Mar; 3(3):e124-5. PubMed ID: 25701988
[No Abstract] [Full Text] [Related]
11. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
Steinberg MH; Barton F; Castro O; Pegelow CH; Ballas SK; Kutlar A; Orringer E; Bellevue R; Olivieri N; Eckman J; Varma M; Ramirez G; Adler B; Smith W; Carlos T; Ataga K; DeCastro L; Bigelow C; Saunthararajah Y; Telfer M; Vichinsky E; Claster S; Shurin S; Bridges K; Waclawiw M; Bonds D; Terrin M
JAMA; 2003 Apr; 289(13):1645-51. PubMed ID: 12672732
[TBL] [Abstract][Full Text] [Related]
12. New treatments of sickle cell disease.
Embury SH
West J Med; 1996 May; 164(5):444. PubMed ID: 8686307
[No Abstract] [Full Text] [Related]
13. Sickle cell patients find a brand New World.
Noonan SS
N J Med; 1999 Aug; 96(8):23-5. PubMed ID: 10457727
[TBL] [Abstract][Full Text] [Related]
14. Principles and indications of chronic transfusion therapy for children with sickle cell disease.
Ware R
Clin Adv Hematol Oncol; 2007 Sep; 5(9):686-8. PubMed ID: 17982409
[No Abstract] [Full Text] [Related]
15. Effects of hydroxyurea administration on the body weight, body composition and exercise performance of patients with sickle-cell anaemia.
Hackney AC; Hezier W; Gulledge TP; Jones S; Strayhorn D; Busby M; Hoffman E; Orringer EP
Clin Sci (Lond); 1997 May; 92(5):481-6. PubMed ID: 9176021
[TBL] [Abstract][Full Text] [Related]
16. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
Greenway A; Ware RE; Thornburg CD
Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome.
Brachet C; Azzi N; Demulder A; Devalck C; Gourdin A; Gulbis B; Klein A; Le PQ; Loop M; Sariban E; Ferster A
Bone Marrow Transplant; 2004 Apr; 33(8):799-803. PubMed ID: 14767501
[TBL] [Abstract][Full Text] [Related]
18. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.
Lê PQ; Ferster A; Cotton F; Vertongen F; Vermylen C; Vanderfaeillie A; Dedeken L; Heijmans C; Ketelslegers O; Dresse MF; Gulbis B
Med Trop (Mars); 2010 Dec; 70(5-6):467-70. PubMed ID: 21516988
[TBL] [Abstract][Full Text] [Related]
19. Hydroxycarbamide for sickle-cell anaemia in infancy.
Weatherall DJ
Lancet; 2011 May; 377(9778):1628-30. PubMed ID: 21571132
[No Abstract] [Full Text] [Related]
20. Hydroxurea and sickle cell disease: Its been a long, long time coming.
Scott JP
Pediatr Blood Cancer; 2010 Feb; 54(2):185-6. PubMed ID: 19908298
[No Abstract] [Full Text] [Related]
[Next] [New Search]